Isis Strategizes In Diabetes
This article was originally published in Scrip
Executive Summary
Isis Pharmaceuticals is not a company that automatically springs to mind when discussing diabetes therapies, but the firm has several programs in development and is pursuing a novel strategy that might see it become an important team player in the future of diabetes treatment.